Ashish V. Shah

home / authors / ashish-v-shah

CEO of Dina

Articles

As Home-Based Supplemental Benefits Explode, Health Plans Embrace Digital Tools to Improve Access to Services

As Home-Based Supplemental Benefits Explode, Health Plans Embrace Digital Tools to Improve Access to Services

Ashish V. Shah
December 5th 2022

Payers face the logistical challenge of coordinating a network of new, non-medical services to ensure members are referred to the right provider at the right time.

Read More

Navigating the Shift to Home-Based Care: 4 Strategies for Success | Ashish V. Shah

Navigating the Shift to Home-Based Care: 4 Strategies for Success | Ashish V. Shah

Ashish V. Shah
July 8th 2022

One trend to keep an eye on is the establishment of “care traffic control” centers to remotely monitor patients and use home-based insights to identify risks and inform care plans.

Read More

Latest Updated Articles

Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
black and white image of solders in jungle setting | ©daniel stock.adobe.com
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
food in heart shape with a stethoscope | image credit: ©udra11
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
The future of diabetes management: expanding access to and impact of CGM for patients with type 2 diabetes
Published: July 16th 2025 | Updated: July 31st 2025
The future of diabetes management: expanding access to and impact of CGM for patients with type 2 diabetes
For GLP-1s and Biosimilars, Some Celebration, Some Concern, Survey Finds | MHE 2025 Pharmacy Survey, Part 3
Published: May 20th 2025 | Updated: July 31st 2025
For GLP-1s and Biosimilars, Some Celebration, Some Concern, Survey Finds | MHE 2025 Pharmacy Survey, Part 3
© 2025 MJH Life Sciences

All rights reserved.